For AI-powered Gene Therapy
and Product Development.
——Westlake Genetech (Hangzhou) Co., Ltd.
Company Profile
About US
Westlake Genetech (Hangzhou) Co., Ltd. is an innovative biotech company, a start-up from scientific research achievements of Westlake University, which is committed to mapping the full-process implementation of AI-powered Gene Therapy.
Technology Platform
TECHNOLOGY
News
NEWS
04-05
2024
Lijia Ma's team at Westlake University discovered that the transpeptidase sortase binds nucleic acid molecules and mediates cell labeling with nucleic acids
On April 5, 2024, Lijia Ma(the Founder of Westlake Genetech and researcher at the School of Life Sciences, Westlake University), along with team members, published a research paper titled
"The transpeptidase sortase A binds nucleic acids and mediates mammalian cell labeling" in Advanced Science.
02-21
2024
02-14
2024
The team from Westlake Genetech developed a machine learning-based prediction model to guide the selection of Cas9 variants
On February 14, 2024, members of the founding team of Westlake Genetech published a paper entitled
"Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing" in Cell Reports.
01-26
2024
01-09
2024
